Lambert-Eaton myasthenic syndrome commonly seen in small-cell lung cancer r
epresents an autoimmune reaction against antigens coexpressed by tumor and
neurons. It is rarely seen with other histologic subtypes. Symptoms antedat
e the appearance of the neoplasm by weeks to years. Therapeutic options ran
ge from immunosuppression, plasmapheresis, pharmacologic facilitation of ne
uromuscular transmission, and definitive therapy of the primary tumor. This
case report describes the rare association of Lambert-Eaton myasthenic syn
drome with non-small-cell lung cancer.